Compare Blackrock Inc (BLK) vs Johnson & Johnson (JNJ) Price & Performance

BlackRock (BLK) trades at $1,153.57, up 1.96% today, reflecting strong momentum. The stock shows bullish technical signals with consistent earnings beats in recent quarters, including Q2 2026 EPS of $13.91 versus $12.69 expected. Revenue grew to $24.22 billion in 2025, though net income margin dipped to 22.93%. Recent news highlights BlackRock's involvement in a $500 billion AI financing initiative with partners like Apollo and Nvidia, signaling strategic growth avenues.

The outlook remains positive with a consensus price target of $1,350, implying 17% upside. Key opportunities include robust analyst support (79% buy ratings) and dividend stability, while risks involve legal investigations into mutual fund practices and volatile cash flows, with net cash flow negative $1.29 billion in 2025. Investors should weigh solid fundamentals against regulatory and execution risks.

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.